8.40
0.08 (0.96%)
0.08 (0.96%)
Upgrade to Real-Time
Premarket
Low
3.25
High
24.90
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.08 | 0.96% | 8.40 | 08:51:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.32 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 8.39 | 8.43 | 0.04 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 343 | 68,120 | 10,766,524 | 3.25 - 24.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:52:50 | 4 | $ 8.42 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.03B | 122.27M | 121.55M | $ 4.05M | $ - | -0.35 | -16.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -350.00k | 2.20% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.34 | 9.00 | 7.57 | 7.96 | 11,096,498 | 0.06 | 0.72% |
| 1 Month | 6.65 | 10.00 | 6.45 | 8.17 | 13,901,159 | 1.75 | 26.32% |
| 3 Months | 6.25 | 11.108 | 4.862 | 8.52 | 21,275,680 | 2.15 | 34.4% |
| 6 Months | 6.93 | 24.90 | 4.862 | 9.13 | 17,122,828 | 1.47 | 21.21% |
| 1 Year | 3.61 | 24.90 | 3.25 | 8.97 | 20,270,790 | 4.79 | 132.69% |
| 3 Years | 3.12 | 24.90 | 0.2543 | 7.63 | 8,468,051 | 5.28 | 169.23% |
| 5 Years | 15.18 | 24.90 | 0.2543 | 7.63 | 5,266,179 | -6.78 | -44.66% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
